HKG:9939

3 stories mentioning HKG:9939

Every FINWIRES story that references HKG:9939, newest first.

Kintor Pharma Posts Positive Interim Safety Data for Whitening Agent KT-939

Kintor Pharmaceutical (HKG:9939) posted positive interim results from a long-term human safety trial of KT-939 and has begun the registration process for the compound as a new cosmetic ingredient in China, according to a Wednesday Hong Kong bourse filing.The company said 119 participants received continuous topical treatment with KT-939 for 28 weeks, with no adverse skin reactions reported.The trial is evaluating the safety of a cosmetic formulation containing 0.2% KT-939 over 52 consecutive weeks and is expected to be completed in September.

HKG:9939

Asia19d ago

Kintor Pharmaceutical Auditor to Retire; Shares Drop 7%

Kintor Pharmaceutical (HKG:9939) said its long-time auditor PricewaterhouseCoopers will retire at the company's upcoming annual meeting in June, according to a Tuesday filing with the Hong Kong bourse.The pharmaceutical company's shares fell nearly 7% in late morning trade Wednesday.The firm said it planned to appoint Rongcheng (Hong Kong) as its new auditor.

HKG:9939

Asia55d ago

Kintor Pharmaceutical's 2026 Sales Jump Past 2025 Full-Year Level

Kintor Pharmaceutical (HKG:9939) said its sales since the start of 2026 have exceeded its full-year 2025 total, driven by strong growth in its B2C and B2B businesses, according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were up nearly 2% in Tuesday morning trade.The company said year-to-date revenue reached about 34 million yuan, surpassing the 32.7 million yuan sales recorded for all of last year.Kintor said it plans to use cash flow from these businesses to support the development and commercialization of its core drug pipeline.

HKG:9939